Ategra Capital Management, LLC Amgen Inc Transaction History

Ategra Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2025	SELL	$229.03 - $291.01 $1.6 Million - $2.03 Million	-6,986 Closed	0 $0
Q3 2022 Feb 13, 2025	SELL	$224.46 - $253.15 $1.05 Million - $1.18 Million	-4,675 Reduced 40.09%	6,986 $1.57 Billion
Q2 2022 Feb 13, 2025	SELL	$230.71 - $256.74 $7,844 - $8,729	-34 Reduced 0.29%	11,661 $2.84 Billion
Q1 2022 Feb 13, 2025	BUY	$219.27 - $242.57 $41,442 - $45,845	189 Added 1.64%	11,695 $2.83 Billion
Q4 2021 Feb 13, 2025	BUY	$198.88 - $227.6 $1.03 Million - $1.18 Million	5,178 Added 81.83%	11,506 $2.59 Billion
Q3 2021 Feb 13, 2025	BUY	$212.27 - $248.7 $982,173 - $1.15 Million	4,627 Added 272.02%	6,328 $1.35 Billion
Q3 2020 Feb 13, 2025	SELL	$234.65 - $260.95 $6,804 - $7,567	-29 Reduced 1.68%	1,701 $432 Million
Q1 2020 Feb 13, 2025	BUY	$182.24 - $241.7 $7,289 - $9,668	40 Added 2.37%	1,730 $351 Million
Q2 2019 Feb 13, 2025	SELL	$166.7 - $195.41 $8,668 - $10,161	-52 Reduced 2.99%	1,690 $311 Million
Q1 2019 Feb 13, 2025	BUY	$180.87 - $203.88 $315,075 - $355,158	1,742 New	1,742 $331 Million

3,167

418M

8.25M

6.39M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Ategra Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ategra Capital Management, LLC with notifications on news.